⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTB News
Connect Biopharma Holdings Limited Ordinary Shares
Form 8-K
sec.gov
CNTB
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
globenewswire.com
CNTB
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
accessnewswire.com
INAB
DMAC
NSRX
CNTB
CLDI
Form 8-K
sec.gov
CNTB
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
globenewswire.com
CNTB
Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth
businesswire.com
CNTB
Form 8-K
sec.gov
CNTB
Connect Biopharma Announces $20.2 Million Private Placement Financing
globenewswire.com
CNTB
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
globenewswire.com
CNTB
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
globenewswire.com
CNTB